Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.74−0.08 (-9.49%)
Close on Nov 17, 2026Market cap $68.60MP/E –Yield –
Anavex Life Sciences operating margin
Operating margin is operating income as a percentage of revenue.
No operating margin figures for Anavex Life Sciences
Anavex Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?